Clinical Trials Browser

Phase 2 × Carcinoma, Hepatocellular × amivantamab × Clear all

NCT05653427 2025-01-13

A Study of Amivantamab Monotherapy in Participants With Previously Treated Advanced Hepatocellular Carcinoma

Phase 2 Terminated

18 enrolled 20 charts

Gastrointestinal

Carcinoma, Hepatocellular